CN109152743B - 含有度他雄胺和坦索罗辛的硬胶囊复合物及其制备方法 - Google Patents

含有度他雄胺和坦索罗辛的硬胶囊复合物及其制备方法 Download PDF

Info

Publication number
CN109152743B
CN109152743B CN201780029107.0A CN201780029107A CN109152743B CN 109152743 B CN109152743 B CN 109152743B CN 201780029107 A CN201780029107 A CN 201780029107A CN 109152743 B CN109152743 B CN 109152743B
Authority
CN
China
Prior art keywords
dutasteride
tamsulosin
moiety
independent
hard capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780029107.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN109152743A (zh
Inventor
李炳俊
金唇哲
金载镐
金用镒
朴宰贤
禹钟守
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of CN109152743A publication Critical patent/CN109152743A/zh
Application granted granted Critical
Publication of CN109152743B publication Critical patent/CN109152743B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201780029107.0A 2016-03-16 2017-03-16 含有度他雄胺和坦索罗辛的硬胶囊复合物及其制备方法 Active CN109152743B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20160031468 2016-03-16
KR10-2016-0031468 2016-03-16
PCT/KR2017/002862 WO2017160106A2 (ko) 2016-03-16 2017-03-16 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법

Publications (2)

Publication Number Publication Date
CN109152743A CN109152743A (zh) 2019-01-04
CN109152743B true CN109152743B (zh) 2022-01-07

Family

ID=59850978

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780029107.0A Active CN109152743B (zh) 2016-03-16 2017-03-16 含有度他雄胺和坦索罗辛的硬胶囊复合物及其制备方法

Country Status (8)

Country Link
KR (1) KR101968754B1 (ru)
CN (1) CN109152743B (ru)
AU (1) AU2017233134A1 (ru)
BR (1) BR112018068686A2 (ru)
EA (1) EA201891843A1 (ru)
MX (1) MX2018011208A (ru)
PH (1) PH12018501985A1 (ru)
WO (1) WO2017160106A2 (ru)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102145007A (zh) * 2011-03-03 2011-08-10 王致中 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
UA80393C2 (ru) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице
PT1618873E (pt) * 2004-07-14 2007-09-04 Siegfried Generics Int Ag Grânulos para libertação controlada de tamsulosina, que contém alginato.
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
CN102247379A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种复方制剂及其制备方法
WO2014002015A1 (en) * 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
BR112015021769A2 (pt) * 2013-03-19 2017-07-18 Galenicum Health Sl composições farmacêuticas compreendendo um agente ativo
KR20160021095A (ko) * 2013-06-21 2016-02-24 욱크하르트 리미티드 탐술로신 또는 이의 염의 약학 조성물
EP2949319A1 (en) * 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
KR101590072B1 (ko) * 2014-12-23 2016-01-29 한미약품 주식회사 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102145007A (zh) * 2011-03-03 2011-08-10 王致中 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法

Also Published As

Publication number Publication date
WO2017160106A2 (ko) 2017-09-21
BR112018068686A2 (pt) 2019-01-15
EA201891843A1 (ru) 2019-04-30
KR101968754B1 (ko) 2019-04-12
WO2017160106A3 (ko) 2018-09-07
MX2018011208A (es) 2019-05-30
AU2017233134A1 (en) 2018-10-04
CN109152743A (zh) 2019-01-04
PH12018501985A1 (en) 2019-07-08
KR20170107933A (ko) 2017-09-26

Similar Documents

Publication Publication Date Title
JP7394974B2 (ja) 酢酸アビラテロンを含む医薬組成物、並びにその製造方法及び使用
RU2435568C2 (ru) Таблетки с высвобождением активного ингредиента, происходящим в определенном месте и в определенное время
ES2663135T3 (es) Formulaciones orales de deferasirox
US20110008426A1 (en) Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
WO2006070781A1 (ja) 塩基性薬物又はその塩を含有するマトリックス型徐放性製剤およびその製造方法
JP2009500317A (ja) 放出特性改良医薬組成物およびその製造方法
RU2716025C1 (ru) ЛЕКАРСТВЕННАЯ ФОРМА С УЛУЧШЕННЫМИ ХАРАКТЕРИСТИКАМИ pH-ЗАВИСИМОГО ВЫСВОБОЖДЕНИЯ ПРЕПАРАТА, СОДЕРЖАЩАЯ ЭЗОМЕПРАЗОЛ ИЛИ ЕГО ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМУЮ СОЛЬ
JP2008534586A (ja) フェノフィブレートの改良された製剤
ES2772137T3 (es) Preparación de composite que comprende una capa de recubrimiento pelicular que contiene principio activo
JP2014196334A (ja) クエチアピンを含む徐放性医薬組成物
EP3302412A1 (en) Once daily oral pharmaceutical composition of isotretinoin
EP3013327A1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
KR100798730B1 (ko) 록소프로펜 또는 잘토프로펜 함유 제어방출성 제제 및 그의제조방법
JP2020500864A (ja) 経口トリデカン酸テストステロン療法
KR20220087443A (ko) 셀렉시파그를 포함하는 약제학적 조성물
CN109890372B (zh) 含埃索美拉唑的复合胶囊及其制备方法
WO2010023690A2 (en) Prolonged release formulation of amisulpride
CN109152743B (zh) 含有度他雄胺和坦索罗辛的硬胶囊复合物及其制备方法
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
US10034865B2 (en) Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof
WO2014003371A1 (ko) 아세브로필린을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물
WO2014002015A1 (en) Pharmaceutical composition comprising dutasteride
KR102081095B1 (ko) 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제
JP2021518422A (ja) レナリドミドを含む医薬組成物
KR102216579B1 (ko) 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant